UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Factor Xa Activation of Factor V Is of Paramount Importance in Initiating the Coagulation System: Lessons From a Tick Salivary Protein

Circulation (New York, N.Y.), 2013-07, Vol.128 (3), p.254-266

2013

Link zum Volltext

Verfügbarkeit prüfen

Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex

Journal of innate immunity, 2023-01, Vol.15 (1), p.16-36

2023

Link zum Volltext

Verfügbarkeit prüfen

Thrombin activation of the factor XI dimer is a multistaged process for each subunit

Journal of thrombosis and haemostasis, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (20), p.9083-9087

2010

Link zum Volltext

Verfügbarkeit prüfen

A FRET-based assay for the quantitation of the thrombin-factor XI interaction

Thrombosis research, 2022-06, Vol.214, p.23-28

2022

Link zum Volltext

Verfügbarkeit prüfen

Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

Thrombosis and haemostasis, 2011-10, Vol.106 (4), p.609

2011

Link zum Volltext

Verfügbarkeit prüfen

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2538-2549

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

Blood, 2015-03, Vol.125 (11), p.1822-1825

2015

Link zum Volltext

Verfügbarkeit prüfen

Hydrogen‐deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa

Journal of thrombosis and haemostasis, 2019-12, Vol.17 (12), p.2047-2055

2019

Link zum Volltext

Verfügbarkeit prüfen

β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Blood, 2010-08, Vol.116 (8), p.1336-1343

2010

Link zum Volltext

Verfügbarkeit prüfen

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI

Thrombosis and haemostasis, 2018-02, Vol.118 (2), p.340

2018

Link zum Volltext

Verfügbarkeit prüfen

proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking

The FASEB journal, 2009-05, Vol.23 (5), p.1584-1595

2009

Link zum Volltext

Verfügbarkeit prüfen

Structure‐function of anticoagulant TIX‐5, the inhibitor of factor Xa‐mediated FV activation

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1697-1708

2021

Link zum Volltext

Verfügbarkeit prüfen

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model

Thrombosis and haemostasis, 2013-11, Vol.110 (5), p.1065

2013

Link zum Volltext

Verfügbarkeit prüfen

Generation and Characterization of a Highly Stable Form of Activated Thrombin-activable Fibrinolysis Inhibitor

The Journal of biological chemistry, 2004-02, Vol.279 (8), p.6620-6628

2004

Link zum Volltext

Verfügbarkeit prüfen

The Design and Characterization of Receptor-selective APRIL Variants

The Journal of biological chemistry, 2012-10, Vol.287 (44), p.37434-37446

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein C inhibitor (plasminogen activator inhibitor‐3) and the risk of venous thrombosis

British journal of haematology, 2002-08, Vol.118 (2), p.604-609

2002

Link zum Volltext

Verfügbarkeit prüfen

Evolutionary conservation of the lipopolysaccharide binding site of β₂-glycoprotein I

Thrombosis and haemostasis, 2011-12, Vol.106 (6), p.1069

2011

Link zum Volltext

Verfügbarkeit prüfen

β2‐Glycoprotein I is incorrectly named apolipoprotein H

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.235-236

2009

Link zum Volltext

Verfügbarkeit prüfen

Thrombin activation of the factor XI dimer is a multi-staged process for each subunit

Journal of thrombosis and haemostasis, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

beta(2)-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Blood, 2010-08, Vol.116 (8), p.1336

2010

Link zum Volltext

Verfügbarkeit prüfen

Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains

Thrombosis and haemostasis, 2000-12, Vol.84 (6), p.1005

2000

Link zum Volltext

Verfügbarkeit prüfen

The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization andcross‐linking

The FASEB journal, 2009-05, Vol.23 (5), p.1584-1595

2009

Link zum Volltext

Verfügbarkeit prüfen

Protein C Inhibitor May Modulate Human Sperm-Oocyte Interactions1

Biology of reproduction, 1998-03, Vol.58 (3), p.670-677

1998

Link zum Volltext

Verfügbarkeit prüfen

Beta2-glycoprotein I is incorrectly named apolipoprotein H

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.235-236

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factor Xa Activation of Factor V Is of Paramount Importance in Initiating the Coagulation System: Lessons From a Tick Salivary Protein

Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex

Thrombin activation of the factor XI dimer is a multistaged process for each subunit

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

A FRET-based assay for the quantitation of the thrombin-factor XI interaction

Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

Hydrogen‐deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa

β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI

proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking

Structure‐function of anticoagulant TIX‐5, the inhibitor of factor Xa‐mediated FV activation

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model

Generation and Characterization of a Highly Stable Form of Activated Thrombin-activable Fibrinolysis Inhibitor

The Design and Characterization of Receptor-selective APRIL Variants

Protein C inhibitor (plasminogen activator inhibitor‐3) and the risk of venous thrombosis

Evolutionary conservation of the lipopolysaccharide binding site of β₂-glycoprotein I

β2‐Glycoprotein I is incorrectly named apolipoprotein H

Thrombin activation of the factor XI dimer is a multi-staged process for each subunit

beta(2)-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains

The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization andcross‐linking

Protein C Inhibitor May Modulate Human Sperm-Oocyte Interactions1

Beta2-glycoprotein I is incorrectly named apolipoprotein H

Suchergebnisse filtern